Sickle Cell Disease Drug Development Pipeline Review, 2017

"The Report Sickle Cell Disease Drug Development Pipeline Review, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

About Sickle Cell Disease Drug Development Market

This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and vaso-occlusive crisis associated with sickle cell disease, and features dormant and discontinued projects.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1394151

Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. There are a total of 62 products in development for this indication, by 45 companies and nine academic institutions. Hemoglobin and a range of histone deacetylases are the most common molecular targets being studied in sickle cell anemia.

Vaso-occlusive crisis associated with sickle cell disease is a painful episode that occurs in people who have sickle cell anemia. Symptoms include fever, pain, fatigue, abdominal pain and swelling, headaches, shortness of breath, dehydration and infection. There are a total of 10 products in development for this indication.

View Report @ https://www.marketresearchreports.biz/reports/1394146/global-stent-grafts-detailed-analysis-report-2017-2022-market-research-reports

Scope

- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1394151

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sickle Cell Disease Report Coverage 7
2.2 Sickle Cell Disease Overview 7
2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Overview 7
3 Therapeutics Development 8
3.1 Sickle Cell Disease 8
3.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 15
4 Therapeutics Assessment 18
4.1 Sickle Cell Disease 18
4.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 25
5 Companies Involved in Therapeutics Development 31
5.1 Sickle Cell Disease 31
5.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 47
6 Dormant Projects 52
6.1 Sickle Cell Disease 52
6.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 54
7 Discontinued Products 55
7.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 55
8 Product Development Milestones 56
8.1 Sickle Cell Disease 56
8.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 67
9 Appendix 76
9.1 Methodology 76
9.2 Coverage 76
9.3 Secondary Research 76
9.4 Primary Research 76
9.5 Expert Panel Validation 76
9.6 Contact Us 77
9.7 Disclaimer 77

1.1 List of Tables
Table 1: Number of Products under Development for Sickle Cell Disease 8
Table 2: Number of Products under Development by Companies, Sickle Cell Disease 9
Table 3: Number of Products under Development by Universities/Institutes, Sickle Cell Disease 11
Table 4: Products under Development by Companies, Sickle Cell Disease 12
Table 5: Products under Development by Universities/Institutes, Sickle Cell Disease 14
Table 6: Number of Products under Development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease 15
Table 7: Number of Products under Development by Companies, Vaso-Occlusive Crisis Associated With Sickle Cell Disease 16
Table 8: Products under Development by Companies, Vaso-Occlusive Crisis Associated With Sickle Cell Disease 17
Table 9: Number of Products by Stage and Target, Sickle Cell Disease 19
Table 10: Number of Products by Stage and Mechanism of Action, Sickle Cell Disease 21
Table 11: Number of Products by Stage and Route of Administration, Sickle Cell Disease 23
Table 12: Number of Products by Stage and Molecule Type, Sickle Cell Disease 24
Table 13: Number of Products by Stage and Target, Vaso-Occlusive Crisis Associated With Sickle Cell Disease 26
Table 14: Number of Products by Stage and Mechanism of Action, Vaso-Occlusive Crisis Associated With Sickle Cell Disease 27
Table 15: Number of Products by Stage and Route of Administration, Vaso-Occlusive Crisis Associated With Sickle Cell Disease 29

Buy Now @ https://www.researchmoz.com/checkout?rep_id=1394151&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.